IGLU Therapeutics Overview
- Year Founded
-
2025
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
IGLU Therapeutics General Information
Description
Developer of gene therapy treatments intended for modifying neurological disorder progression. The company's platform focuses on targeting dysfunction of specific neural receptor pathways through approaches aimed at restoring normal signaling, incorporating techniques for genetic correction, regulated expression, and delivery to affected neural cells, enabling the healthcare and biomedical research market to address rare pediatric neurological conditions with potential long-term functional improvement where existing therapeutic options are limited or absent.
Contact Information
Website
www.iglutherapeutics.comCorporate Office
- Toronto, Ontario
- Canada
Corporate Office
- Toronto, Ontario
- Canada
IGLU Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 25-Nov-2025 | Completed | Startup |
IGLU Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
IGLU Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
IGLU Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Capital BioVentures | Accelerator/Incubator |
IGLU Therapeutics FAQs
-
When was IGLU Therapeutics founded?
IGLU Therapeutics was founded in 2025.
-
Where is IGLU Therapeutics headquartered?
IGLU Therapeutics is headquartered in Toronto, Canada.
-
What is the size of IGLU Therapeutics?
IGLU Therapeutics has 3 total employees.
-
What industry is IGLU Therapeutics in?
IGLU Therapeutics’s primary industry is Drug Discovery.
-
Is IGLU Therapeutics a private or public company?
IGLU Therapeutics is a Private company.
-
What is IGLU Therapeutics’s current revenue?
The current revenue for IGLU Therapeutics is .
-
Who are IGLU Therapeutics’s investors?
Capital BioVentures has invested in IGLU Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
